CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-26 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −35 | $3.42 | $120 | 2,981 |
| 2019-02-26 | Krishnan Ram CEO | Shares withheld for taxes | −285 | $3.42 | $975 | 73,887 |
| 2019-01-29 | Wolff Allen CFO and EVP | Shares withheld for taxes | −171 | $3.18 | $544 | 49,254 |
| 2019-01-29 | Krishnan Ram CEO | Shares withheld for taxes | −284 | $3.18 | $903 | 74,172 |
| 2019-01-29 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −34 | $3.18 | $108 | 3,016 |
| 2018-12-19 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −28 | $2.00 | $56 | 3,050 |
| 2018-12-19 | Krishnan Ram CEO | Shares withheld for taxes | −240 | $2.00 | $480 | 74,456 |
| 2018-12-19 | Wolff Allen CFO and EVP | Shares withheld for taxes | −145 | $2.00 | $290 | 49,425 |
| 2018-11-20 | Wolff Allen CFO and EVP | Shares withheld for taxes | −144 | $2.87 | $413 | 49,570 |
| 2018-11-20 | Krishnan Ram CEO | Shares withheld for taxes | −241 | $2.87 | $692 | 74,696 |
| 2018-11-20 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −29 | $2.87 | $83 | 3,078 |
| 2018-10-23 | Krishnan Ram CEO | Shares withheld for taxes | −240 | $4.32 | $1K | 74,937 |
| 2018-10-23 | Wolff Allen CFO and EVP | Shares withheld for taxes | −145 | $4.32 | $626 | 49,714 |
| 2018-10-23 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −28 | $4.32 | $121 | 3,107 |
| 2018-09-25 | Wolff Allen CFO and EVP | Shares withheld for taxes | −857 | $4.23 | $4K | 49,859 |
| 2018-09-25 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −169 | $4.23 | $715 | 3,135 |
| 2018-09-25 | Krishnan Ram CEO | Shares withheld for taxes | −1,441 | $4.23 | $6K | 75,177 |
| 2018-06-08 | Thomas Gregory Matthew Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 | ||
| 2018-06-08 | Mitgang Steve Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 | ||
| 2018-06-08 | Yanover Paul Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 |
Page 14 of 33 · 657 trades